标题
Etanercept: efficacy and safety for approved indications
作者
关键词
-
出版物
Expert Opinion On Drug Safety
Volume 11, Issue 1, Pages 121-139
出版商
Informa Healthcare
发表日期
2011-11-11
DOI
10.1517/14740338.2012.633509
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Safety and Efficacy of Etanercept in Children with Juvenile-Onset Behcet's Disease
- (2017) L. Cantarini et al. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
- Etanercept plus narrowband ultraviolet B phototherapy of psoriasis is more effective than etanercept monotherapy at 6 weeks
- (2011) T. Gambichler et al. BRITISH JOURNAL OF DERMATOLOGY
- TNF alpha antagonist-induced lupus-like syndrome: report and review of the literature with implications for treatment with alternative TNF alpha antagonists
- (2011) Victoria L. Williams et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Long-term safety of anti-TNF treatment in patients with rheumatic diseases and chronic or resolved hepatitis B virus infection
- (2010) D. Vassilopoulos et al. ANNALS OF THE RHEUMATIC DISEASES
- Incidence and risk of hospitalisation due to shingles and chickenpox in patients with rheumatic diseases treated with TNF antagonists
- (2010) I. Garcia-Doval et al. ANNALS OF THE RHEUMATIC DISEASES
- Drug-specific risk of non-tuberculosis opportunistic infections in patients receiving anti-TNF therapy reported to the 3-year prospective French RATIO registry
- (2010) D. Salmon-Ceron et al. ANNALS OF THE RHEUMATIC DISEASES
- Is Etanercept Safe for Treating Plaque Psoriasis in a Patient With Chronic Hepatitis C Virus Infection?
- (2010) Rishi K. Gandhi et al. ARCHIVES OF DERMATOLOGY
- Tumor necrosis factor α blockers and malignancy in children: Forty-eight cases reported to the food and drug administration
- (2010) Peter Diak et al. ARTHRITIS AND RHEUMATISM
- Is antitumour necrosis factor therapy combined with ultraviolet B phototherapy safe?
- (2010) V. Di Lernia et al. BRITISH JOURNAL OF DERMATOLOGY
- Epidemiology and survival of Merkel cell carcinoma in the Netherlands. A population-based study of 808 cases in 1993–2007
- (2010) B.A. Reichgelt et al. EUROPEAN JOURNAL OF CANCER
- Biologics in children’s autoimmune disorders: efficacy and safety
- (2010) Luciana Breda et al. EUROPEAN JOURNAL OF PEDIATRICS
- Combination systemic therapies in psoriatic arthritis
- (2010) Meaghan Daly et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- New-onset psoriasis associated with etanercept therapy
- (2010) Lu-An CHEN et al. JOURNAL OF DERMATOLOGY
- Chronic inflammatory demyelinating polyneuropathy associated with tumor necrosis factor-α antagonists
- (2010) Amer Alshekhlee et al. MUSCLE & NERVE
- Guilt by association - what is the true risk of malignancy in children treated with etanercept for JIA?
- (2010) Randy Q Cron et al. Pediatric Rheumatology
- Summary of worldwide pediatric malignancies reported after exposure to etanercept
- (2010) Peter McCroskery et al. Pediatric Rheumatology
- Anti-TNF Agents for Behçet's Disease: Analysis of Published Data on 369 Patients
- (2010) Aikaterini Arida et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Etanercept during pregnancy and lactation in a patient with rheumatoid arthritis: drug levels in maternal serum, cord blood, breast milk and the infant's serum
- (2009) A Murashima et al. ANNALS OF THE RHEUMATIC DISEASES
- Long-term Course of Demyelinating Neuropathies Occurring During Tumor Necrosis Factor-α–Blocker Therapy
- (2009) Pierre Lozeron et al. ARCHIVES OF NEUROLOGY
- Etanercept-induced pleuropericardial lupus-like syndrome
- (2009) I. Porfyridis et al. EUROPEAN RESPIRATORY JOURNAL
- Treatment of neuro-Behçet’s disease: an update
- (2009) Afshin Borhani Haghighi Expert Review of Neurotherapeutics
- Risk of Herpes Zoster in Patients With Rheumatoid Arthritis Treated With Anti–TNF-α Agents
- (2009) Anja Strangfeld JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Inflammatory Bowel Disease, Clinical
- (2009) JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Safety of Etanercept in Patients at High Risk for Mycobacterial Tuberculosis Infections
- (2009) R. AGGARWAL et al. JOURNAL OF RHEUMATOLOGY
- Use of Tumor Necrosis Factor- -blocking Agents in Hepatitis B Virus-positive Patients: Reports of 3 Cases and Review of the Literature
- (2009) S. ZINGARELLI et al. JOURNAL OF RHEUMATOLOGY
- Etanercept in the Longterm Treatment of Patients With Ankylosing Spondylitis
- (2009) B. DIJKMANS et al. JOURNAL OF RHEUMATOLOGY
- Treatment of psoriasis in patients with hepatitis C: From the Medical Board of the National Psoriasis Foundation
- (2009) Amylynne J. Frankel et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- DisseminatedHistoplasma capsulatuminfection presenting with panniculitis and focal myositis in rheumatoid arthritis treated with etanercept
- (2009) J. Bourré‐Tessier et al. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
- Recent developments in anti-rheumatic drugs in pediatrics: treatment of juvenile idiopathic arthritis
- (2009) Kristen Hayward et al. ARTHRITIS RESEARCH & THERAPY
- Efficacy, safety and patient-reported outcomes of combination etanercept and sulfasalazine versus etanercept alone in patients with rheumatoid arthritis: a double-blind randomised 2-year study
- (2008) B Combe et al. ANNALS OF THE RHEUMATIC DISEASES
- Life-table analysis of etanercept with or without methotrexate in patients with psoriatic arthritis
- (2008) A Spadaro et al. ANNALS OF THE RHEUMATIC DISEASES
- Rates of new-onset psoriasis in patients with rheumatoid arthritis receiving anti-tumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register
- (2008) M J Harrison et al. ANNALS OF THE RHEUMATIC DISEASES
- The comparative one-year performance of anti–tumor necrosis factor α drugs in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: Results from a longitudinal, observational, multicenter study
- (2008) Marte Schrumpf Heiberg et al. ARTHRITIS AND RHEUMATISM
- Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis
- (2008) Daniel J. Lovell et al. ARTHRITIS AND RHEUMATISM
- Treatment with 311-nm ultraviolet B accelerates and improves the clearance of psoriatic lesions in patients treated with etanercept
- (2008) P. Wolf et al. BRITISH JOURNAL OF DERMATOLOGY
- Ophthalmic manifestations of demyelination secondary to etanercept
- (2008) CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Efficacy of etanercept in the treatment of a patient with Behçet’s disease
- (2008) Valentina Curigliano et al. CLINICAL RHEUMATOLOGY
- Inflammatory demyelinating events following treatment with anti-tumor necrosis factor
- (2008) A. Fromont et al. CYTOKINE
- A Randomized, Double-Blinded, Placebo-Controlled Multicenter Trial of Etanercept in the Treatment of Alcoholic Hepatitis
- (2008) Nicholas C. Boetticher et al. GASTROENTEROLOGY
- Guidelines of care for the management of psoriasis and psoriatic arthritis
- (2008) Alan Menter et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Etanercept as a rescue agent in patient with adult onset Still’s disease complicated with congestive heart failure
- (2008) Deng-Ho Yang et al. RHEUMATOLOGY INTERNATIONAL
- Multiple sclerosis following etanercept treatment for ankylosing spondylitis
- (2008) C. F. Pfueller et al. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
- The effect of weight on the efficacy of biologic therapy in patients with psoriasis
- (2007) Lily Clark et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Tumor necrosis factor antagonist mechanisms of action: A comprehensive review
- (2007) Daniel Tracey et al. PHARMACOLOGY & THERAPEUTICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started